Want to join the conversation?
$BDX's 1Q16 US revenue grew 1.5%, with BD Medical growth of 1.9% and BD Life Sciences growth of 0.3%. BD Medical's performance reflects strength in pharmacy solutions, infusion therapy pumps and related consumables. International revenues grew 2.2%, below the normal growth rate reflecting timing of tenders and capital installations.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!